Caliper Life Sciences Develops Customized Transfection System For Boehringer Ingelheim

Caliper Life
Sciences, Inc. (Nasdaq: CALP), an established leader in the field of
robotics, is working with the pharmaceutical industry to develop customized
robotic transfection systems for protein expression. Caliper recently
created a unique solution for Boehringer Ingelheim that automates aspects
of Baculovirus expression.



To develop the system for Boehringer Ingelheim, Caliper's Integrated
Systems Group (ISG) worked directly with researchers to understand the
company's specific needs for each step of the Baculovirus expression
process. Caliper then utilized its expertise in the field of laboratory
automation and robotics to integrate its Sciclone(R) liquid handler along
with technology from third-party vendors to create a Staccato(R) laboratory
system that is reliable, effective and individualized.



Caliper's ISG team, a dedicated team of engineers and scientists with
experience in mechanical and electrical engineering, software development,
assay development and project management expertise, work closely with
customers to design and build each system according to specific needs.



"The capability to develop highly reliable integrated systems
illustrates our commitment to laboratory automation and robotics, and to
providing the pharmaceutical industry with innovative research tools that
meet unique needs," said Kevin Keras, Business Unit Manager, Integrated
Systems, Caliper Life Sciences. "We are dedicated to improving the workflow
for drug discovery and development and see tremendous value in partnering
with leading system providers to create solutions that incorporate a broad
range of capabilities."



About Caliper Life Sciences



Caliper Life Sciences is a leading provider of cutting-edge
technologies enabling researchers in the life sciences to create
life-saving and enhancing medicines and diagnostic tests more quickly and
efficiently. Caliper is aggressively innovating new technology to bridge
the gap between in vitro assays and in vivo results and then translate
those results into cures for human disease. Caliper's portfolio of
offerings includes state-of-the-art microfluidics, lab automation & liquid
handling, optical imaging technologies, and discovery & development
outsourcing solutions. For more information please visit
caliperLS.



Caliper, Sciclone and Staccato are registered trademarks of Caliper
Life Sciences, Inc.


Caliper Life Sciences, Inc

caliperLS